IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma? Plus, we explore the crucial role of patient-reported outcomes in healthcare delivery and examine ...

Since December 2022, and COP decision 15/9, members of the Convention on Biological Diversity (the CBD) have been negotiating a multilateral mechanism for the fair and equitable sharing of benefits ...

Chua et al., discuss how artificial intelligence is transforming breast cancer care by improving detection, diagnosis, prognosis, treatment planning, and patient recovery through advanced machine ...

Professor and Chair, Department of Genetics and Genome Sciences, School of Medicine We use multidisciplinary approaches to identify and characterize genes which cause susceptibility to inherited ...